Muse stem cell treatment is the clinical administration of authentic Dezawa MuseCells® by independent providers through authorized distribution channels — naturally occurring, SSEA-3-verified stem cells — most commonly as an intravenous infusion. MuseCell Innovations is the global IP owner of the method for isolating and concentrating authentic muse cells; independent clinicians determine whether treatment is appropriate for a given patient. This page describes what treatment involves, how the cells work, what makes treatment authentic, and how to find a provider treating patients with Authentic Dezawa MuseCells®.
ScrollThe cells at the center of the treatment are Muse cells — Multilineage-differentiating Stress-Enduring cells — discovered at Tohoku University in 2010 [1]. They are identified by the surface marker SSEA-3, can differentiate into cells of all three germ layers, and are non-tumorigenic in the published research [1, 2]. (The full science: What are Muse cells?)
One fact reframes everything else on this page: you already have them. Muse cells reside naturally in bone marrow, peripheral blood and connective tissue, where they participate in the body’s own repair [2]. As we age, these cells become less effective. Muse cells do not introduce something foreign to your biology. Dezawa MuseCells® supply more of a repair cell your body already runs on — verified, enriched, and delivered where it can work.
Damaged tissue releases a distress signal — sphingosine-1-phosphate — and circulating Muse cells sense it and accumulate selectively at the site of injury. This is why intravenous delivery is the standard route in the published clinical research: the cells do the navigating [2].
At the site, Muse cells phagocytose — literally take in — fragments of the damaged and dying cells. The fragments’ contents, including their transcription factors, are released inside the Muse cell and act directly on its genome [3].
Directed by what they consumed, the cells begin expressing the identity of the damaged tissue within roughly a day and a half, differentiating into the cell types the tissue needs and replacing what was lost [2, 3].
The published clinical research shares the same basic shape:
Authentic muse cells are Dezawa MuseCells® — prepared under license from MuseCell Innovations, verified for SSEA-3(+) identity, and accompanied by a lot-specific Certificate of Analysis issued by an MCI-authorized laboratory. Authentic material reaches doctors through one route: MCI’s authorized network.
The verification is direct, and you can do it yourself: either the clinic appears on the authorized providers list, or the supply can be confirmed with MuseCell Innovations directly — or the material is not authentic Dezawa MuseCells®. No document a seller hands you replaces that check.
The full verification guide: How to verify authentic Muse cells →Eligibility is a clinical judgment, and it belongs solely to the treating physician. Whether Muse cell treatment is appropriate for you depends on your condition, your history, and your provider’s assessment — a conversation to have with your clinician, not a question a website can answer.
What the published record can tell you is where the research stands: peer-reviewed human trials of Muse cell-based preparations have been conducted across several indications — including subacute ischemic stroke, acute myocardial infarction, spinal cord injury, neonatal hypoxic-ischemic encephalopathy, ALS and epidermolysis bullosa — reporting safety, feasibility and efficacy findings specific to each study [2, 4]. Those findings belong to the conditions and protocols studied; they are the starting point for a conversation with your provider, not a promise about an individual outcome. (Every published trial, cited: Muse cell clinical trials.)
Each authorized clinic is published at /patients. Clinics own their own scheduling and consultations — contact them directly.
/patients PhysiciansIf you want to offer authentic Dezawa MuseCells® in your practice, ordering and authorization run through /physicians.
/physiciansThe clinical administration of authentic Dezawa MuseCells® — SSEA-3-verified Muse cells prepared under license from MuseCell Innovations — by an independent provider, most commonly as an intravenous infusion [2]. Treatment decisions are made by the treating clinician.
Most commonly intravenously — Muse cells sense injury signals and accumulate at damaged tissue on their own, which is why the published human trials used the IV route without HLA matching or immunosuppressive drugs [2, 4]. Some treatment plans include local injection at the site of concern which may include image guidance such as ultrasound or fluoroscopy.
Three things: whether the provider appears on MCI’s authorized list at /patients; whether the product is authentic Dezawa MuseCells®; and whether the Certificate of Analysis carries independent laboratory data for your specific lot, traceable to an MCI-authorized laboratory listed at /physicians.
Check the authorized clinics list at /patients — published and maintained by MuseCell Innovations, the global IP owner. If a clinic offering Muse cell treatment is not on that list and cannot be confirmed by MCI directly, the material is not authentic Dezawa MuseCells®.
Safety is a property of a specific material, not of a category name. The published human trials of Muse cell-based preparations reported their safety findings study by study, across six indications, with donor cells administered intravenously without HLA matching or immunosuppressive drugs [2, 4]. That record belongs to verified, SSEA-3-characterized preparations — which is why verifying authenticity is a safety step, not a formality. How to verify →
Administration is most commonly intravenous. Where a treatment plan includes local injection, a proper provider uses sterile technique and may use image guidance (ultrasound or fluoroscopy), and sets expectations around comfort as with any outpatient injection procedure. Specifics are your provider’s to walk you through.
PRP (platelet-rich plasma) concentrates growth factors from your own blood; it contains no stem cells. Stem cell treatment administers living cells. Within that category, material identity matters: Muse cell treatment uses a defined, SSEA-3-verified cell population with its own published clinical research [2]. Which approach fits your situation is a clinical judgment for your treating physician.
